Brian Kobilka MD
Cardiology
Professor, Molecular & Cellular Physiology, Stanford University Medical Center
Join to View Full Profile
279 Campus Dr# BeckmanStanford, CA 94305
Phone+1 650-723-7069
Dr. Kobilka is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Cardiovascular Disease, 1984 - 1987
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1981 - 1984
Yale School of MedicineClass of 1981
Certifications & Licensure
CA State Medical License 1990 - 2026
NC State Medical License 1984 - 1999
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1995
- Investigator Alumnus Howard Hughes Medical Institute, 1987
Publications & Presentations
PubMed
- The role of intrinsically disordered domains in regulating G protein coupled receptor signaling.Jun Xu, Ruoyi Qiu, Alexander M Garces, Harald Hübner, Xinyu Xu
Biorxiv. 2025-09-11 - 1 citationsMembrane phosphoinositides allosterically tune β-arrestin dynamics to facilitate GPCR core engagement.John Janetzko, Jonathan Deutsch, Yuqi Shi, Dirk H Siepe, Matthieu Masureel
Biorxiv. 2025-07-23 - Ligand-dependent G protein dynamics underlying opioid signaling efficacy.Jonathan Deutsch, Daniel Hilger, John Janetzko, Charles M Schroeder, Steven Chu
Biorxiv. 2025-07-05
Journal Articles
- Structural Mechanisms of Selectivity and Gating in Anion ChannelrhodopsinsKarl Deisseroth, Lief E Fenno, Brian K Kobilka, Nature
- Crystal Structure of the Natural Anion-Conducting Channelrhodopsin GtACR1Lief E Fenno, Karl Deisseroth, Brian K Kobilka, Nature
- Structure of the Μ-opioid Receptor–Gi Protein ComplexBrian Kobilka, MD, Nature
Press Mentions
WashU, Pharmacy Scientists Alter Fentanyl, Aim to Make It Less Lethal, Less AddictiveNovember 30th, 2022- WashU, Pharmacy Scientists Alter Fentanyl, Aim to Make It Less Lethal, Less AddictiveNovember 30th, 2022
- The Many Ways Stanford Medicine Is Responding to the Opioid CrisisMay 6th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
